-
Subject Areas on Research
-
30-day mortality and readmission after hemorrhagic stroke among Medicare beneficiaries in Joint Commission primary stroke center-certified and noncertified hospitals.
-
A New Protocol for Anticoagulation With Tirofiban During Flow Diversion.
-
A blood-based biomarker panel to detect acute stroke.
-
A history of stroke/transient ischemic attack indicates high risks of cardiovascular event and hemorrhagic stroke in patients with coronary artery disease.
-
Acute coronary syndromes. STREAMlining care for patients with STEMI.
-
Administration of 4-Factor Prothrombin Complex Concentrate as an Antidote for Intracranial Bleeding in Patients Taking Direct Factor Xa Inhibitors.
-
Advances in Stroke 2017.
-
Advances in antithrombotic therapy in acute myocardial infarction: the ExTRACT-TIMI 25 and OASIS-6 Trials.
-
Advances in primary stroke prevention.
-
Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors.
-
Andexanet alfa and four-factor prothrombin complex concentrate for reversal of apixaban and rivaroxaban in patients diagnosed with intracranial hemorrhage.
-
Antecedents and Outcomes of Abnormal Cranial Imaging in Moderately Preterm Infants.
-
Anticoagulation Type and Early Recurrence in Cardioembolic Stroke: The IAC Study.
-
Antithrombotic therapy in atrial fibrillation.
-
Apolipoprotein Eɛ2 Is Associated with New Hemorrhage Risk in Brain Arteriovenous Malformations.
-
Approach to Imaging in Patients with Spontaneous Intracranial Hemorrhage.
-
Aspirin for prevention of subarachnoid hemorrhage: the stage is set for a randomized controlled trial.
-
Association Between Endovascular Therapy Time to Treatment and Outcomes in Patients With Basilar Artery Occlusion.
-
Association of Recent Use of Non-Vitamin K Antagonist Oral Anticoagulants With Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Treated With Alteplase.
-
Association of common candidate variants with vascular malformations and intracranial hemorrhage in hereditary hemorrhagic telangiectasia.
-
Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial.
-
Bolus fibrinolysis: risk, benefit, and opportunities.
-
Brain ablation in the rat cerebral cortex using a tunable-free electron laser.
-
Brain microvascular injury and white matter disease provoked by diabetes-associated hyperamylinemia.
-
Brainstem melanomas presenting as a cavernous malformation.
-
Characteristics of strokes associated with centrifugal flow left ventricular assist devices.
-
Chronic kidney disease and stroke.
-
Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial.
-
Clinical outcomes of patients with diabetes and atrial fibrillation treated with apixaban: results from the ARISTOTLE trial.
-
Coexistent Sickle Cell Disease Has No Impact on the Safety or Outcome of Lytic Therapy in Acute Ischemic Stroke: Findings From Get With The Guidelines-Stroke.
-
Comparison of Clinical Care and In-Hospital Outcomes of Asian American and White Patients With Acute Ischemic Stroke.
-
Comparison of Fatal or Irreversible Events With Extended-Duration Betrixaban Versus Standard Dose Enoxaparin in Acutely Ill Medical Patients: An APEX Trial Substudy.
-
Comparison of the Incidence of Major Bleeding With Rivaroxaban Use Among Nonvalvular Atrial Fibrillation Patients With Versus Without Diabetes Mellitus.
-
Contemporary trends and predictors of postacute service use and routine discharge home after stroke.
-
Cost efficiency of anticoagulation with warfarin to prevent stroke in medicare beneficiaries with nonvalvular atrial fibrillation.
-
Cost-effectiveness of antiplatelet agents in secondary stroke prevention: the limits of certainty.
-
Declining stroke mortality in young adults: hope and concern.
-
Delays in Door-to-Needle Times and Their Impact on Treatment Time and Outcomes in Get With The Guidelines-Stroke.
-
Disseminated aspergillosis involving the brain: distribution and imaging characteristics.
-
Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative.
-
Dual antiplatelet therapy.
-
Dual-Energy CT to Differentiate Small Foci of Intracranial Hemorrhage from Calcium.
-
Early Chemoprophylaxis Against Venous Thromboembolism in Patients With Traumatic Brain Injury.
-
Early biomarkers of stroke.
-
Early ischaemic and haemorrhagic complications after atrial fibrillation-related ischaemic stroke: analysis of the IAC study.
-
Effect of Alteplase Use on Outcomes in Patients With Atrial Fibrillation: Analysis of the Initiation of Anticoagulation After Cardioembolic Stroke Study.
-
Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial.
-
Efficacy and safety of reduced-dose non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a meta-analysis of randomized controlled trials.
-
Efficacy and safety of two unfractionated heparin dosing strategies with tenecteplase in acute myocardial infarction (results from Assessment of the Safety and Efficacy of a New Thrombolytic Regimens 2 and 3).
-
Efficacy and safety of unfractionated heparin versus enoxaparin: a pooled analysis of ASSENT-3 and -3 PLUS data.
-
Efficacy of abciximab readministration in coronary intervention.
-
Endovascular stroke intervention in the very young.
-
Eptifibatide and low-dose tissue plasminogen activator in acute myocardial infarction: the integrilin and low-dose thrombolysis in acute myocardial infarction (INTRO AMI) trial.
-
Extracorporeal Membrane Oxygenation for Hemodynamic Support.
-
Fibrinolysis for acute myocardial infarction: current status and new horizons for pharmacological reperfusion, part 2.
-
Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction.
-
Finite element model predictions of intracranial hemorrhage from non-impact, rapid head rotations in the piglet.
-
Gastrointestinal bleeding in patients with atrial fibrillation treated with Apixaban or warfarin: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
-
Genes and environment in neonatal intraventricular hemorrhage.
-
Genetic considerations relevant to intracranial hemorrhage and brain arteriovenous malformations.
-
Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015.
-
Hemorrhagic vestibular schwannoma: review of the literature.
-
Hospitalized hemorrhagic stroke patients with renal insufficiency: clinical characteristics, care patterns, and outcomes.
-
Hypertensive retinopathy and risk of stroke.
-
Immunotherapy, vascular pathology, and microhemorrhages in transgenic mice.
-
Impact of Intracerebral Hematoma Evacuation During Decompressive Hemicraniectomy on Functional Outcomes.
-
Incidence and occurrence of total (first-ever and recurrent) stroke.
-
Influence of gestational age on death and neurodevelopmental outcome in premature infants with severe intracranial hemorrhage.
-
Intracranial haemorrhage with bolus thrombolytic agents.
-
Intracranial haemorrhage with bolus thrombolytic agents.
-
Intracranial hemorrhage among patients with atrial fibrillation anticoagulated with warfarin or rivaroxaban: the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation.
-
Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation therapy.
-
Intracranial hemorrhage in patients with cancer treated with bevacizumab: the Memorial Sloan-Kettering experience.
-
Intravenous Tissue Plasminogen Activator in Stroke Mimics.
-
Intravenous tPA (Tissue-Type Plasminogen Activator) in Patients With Acute Ischemic Stroke Taking Non-Vitamin K Antagonist Oral Anticoagulants Preceding Stroke.
-
Is therapeutic hypothermia during neonatal extracorporeal membrane oxygenation associated with intracranial hemorrhage?
-
Levetiracetam versus (fos)phenytoin for seizure prophylaxis in pediatric patients with intracranial hemorrhage.
-
Low LDL cholesterol, statins, and brain hemorrhage: should we worry?
-
Meta-analysis of intracranial hemorrhage in acute coronary syndromes: incidence, predictors, and clinical outcomes.
-
Minimally Invasive Surgery for Spontaneous Cerebellar Hemorrhage: A Multicenter Study.
-
Monitoring and improving acute stroke care: The North Carolina Stroke Care Collaborative.
-
Mortality, In-Hospital Morbidity, Care Practices, and 2-Year Outcomes for Extremely Preterm Infants in the US, 2013-2018.
-
New heparin dosing recommendations for patients with acute coronary syndromes.
-
Outcomes After Endovascular Thrombectomy With or Without Alteplase in Routine Clinical Practice.
-
Pituitary apoplexy following bilateral total knee arthroplasty.
-
Polymorphisms in genes involved in inflammatory and angiogenic pathways and the risk of hemorrhagic presentation of brain arteriovenous malformations.
-
Predicting symptomatic intracranial haemorrhage after mechanical thrombectomy: the TAG score.
-
Predictors of symptomatic intracranial haemorrhage in patients with an ischaemic stroke with neurological deterioration after intravenous thrombolysis.
-
Race/Ethnic differences in the risk of hemorrhagic complications among patients with ischemic stroke receiving thrombolytic therapy.
-
Rapid growth of an infectious intracranial aneurysm with catastrophic intracranial hemorrhage.
-
Recent Use of Non-Vitamin K Antagonist Oral Anticoagulants and Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Treated With Alteplase-Reply.
-
Recommended primary outcomes for clinical trials evaluating hemostatic blood products and agents in patients with bleeding: Proceedings of a National Heart Lung and Blood Institute and US Department of Defense Consensus Conference.
-
Reduced dose tenecteplase and outcomes in elderly ST-segment elevation myocardial infarction patients: Insights from the STrategic Reperfusion Early After Myocardial infarction trial.
-
Reversal of warfarin associated coagulopathy with 4-factor prothrombin complex concentrate in traumatic brain injury and intracranial hemorrhage.
-
Rho Kinase Inhibition Blunts Lesion Development and Hemorrhage in Murine Models of Aggressive Pdcd10/Ccm3 Disease.
-
Risk factors for intracranial hemorrhage and nonhemorrhagic stroke after fibrinolytic therapy (from the GUSTO-i trial).
-
Risk of hemorrhagic complication associated with ventriculoperitoneal shunt placement in aneurysmal subarachnoid hemorrhage patients on dual antiplatelet therapy.
-
Risk of intracranial haemorrhage with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy in acute myocardial infarction. Dichotomous response as a function of age in the GUSTO V trial.
-
Risk of stroke and bleeding in relation to hypertension in anticoagulated patients with atrial fibrillation: a meta-analysis of randomised controlled trials.
-
Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator.
-
SMFM Fetal Anomalies Consult Series #3: Intracranial Anomalies.
-
Safety and Outcomes of Intravenous tPA in Acute Ischemic Stroke Patients With Prior Stroke Within 3 Months: Findings From Get With The Guidelines-Stroke.
-
Safety of abciximab administration during PCI of patients with previous stroke.
-
Safety of the weight-adjusted dosing regimen of tenecteplase in the ASSENT-Trial.
-
Severe factor V deficiency presenting with intracranial haemorrhage during gestation.
-
Spontaneous brain parenchymal hemorrhage: an approach to imaging for the emergency room radiologist.
-
Statins improve outcome in murine models of intracranial hemorrhage and traumatic brain injury: a translational approach.
-
Stroke Outcomes With Vorapaxar Versus Placebo in Patients With Acute Coronary Syndromes: Insights From the TRACER Trial.
-
Stroke in Patients With Peripheral Artery Disease.
-
Surgical Performance Determines Functional Outcome Benefit in the Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation (MISTIE) Procedure.
-
Survey of patient and physician influences and decision-making regarding CT utilization for minor head injury.
-
The complex relationship between cholesterol and brain hemorrhage.
-
The index case for the fungal meningitis outbreak in the United States.
-
The optimal mode of delivery for the haemophilia carrier expecting an affected infant is caesarean delivery.
-
Thrombin-receptor antagonist vorapaxar in acute coronary syndromes.
-
Thrombolysis in young adults with stroke: Findings from Get With The Guidelines-Stroke.
-
Ticagrelor versus clopidogrel in patients with acute coronary syndromes and a history of stroke or transient ischemic attack.
-
Time to Endovascular Reperfusion and Outcome in Acute Ischemic Stroke : A Nationwide Prospective Registry in China.
-
Toward solving the sedation-assessment conundrum: bi-spectral index monitoring and sedation interruption.
-
Treatment of atrial fibrillation in East Asia: what is perception and what is reality?
-
Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012.
-
Trends in Use, Outcomes, and Disparities in Endovascular Thrombectomy in US Patients With Stroke Aged 80 Years and Older Compared With Younger Patients.
-
Unresolved issues in diagnosis and management of inherited bleeding disorders in the perinatal period: a White Paper of the Perinatal Task Force of the Medical and Scientific Advisory Council of the National Hemophilia Foundation, USA.
-
Use and Outcomes of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients ≥90 Years of Age.
-
Use of Direct Oral Anticoagulant and Outcomes in Patients With Atrial Fibrillation after Transcatheter Aortic Valve Replacement: Insights From the STS/ACC TVT Registry.
-
Use, Temporal Trends, and Outcomes of Endovascular Therapy After Interhospital Transfer in the United States.
-
Vorapaxar in the secondary prevention of atherothrombotic events.
-
Whats and whys with neonatal CT.
-
Keywords of People